Wed, 4 Nov
Amanta Healthcare
Q2 FY27 revenue ₹83.1 Cr (+17%), PAT ₹4.86 Cr (+26%), EBITDA margin 21.6%. The FY27 ₹420–430 Cr target needs a steep H2 ramp the Q2 run-rate doesn't support.
Summary ready
Earnings calls
Amanta Healthcare concalls
Every Amanta Healthcare earnings call we streamed: the live audio and our summary of what management said.
Calls
Q2 FY27: key takeaways
Call page →Q2 FY27 revenue ₹83.1 Cr (+17%), PAT ₹4.86 Cr (+26%), EBITDA margin 21.6%. The FY27 ₹420–430 Cr target needs a steep H2 ramp the Q2 run-rate doesn't support.
Outlook
FY27 revenue ₹420–430 Cr. SVP ₹16 Cr in FY28. Two-year aim: 20%+ revenue CAGR, 25%+ EBITDA margin.
Earlier call summaries
All →
14:47 IST
BSE
Earnings Call
Amanta Healthcare Earnings Call Transcript: Key Takeaways
Amanta Healthcare delivers solid FY26 results with significant profit growth, transitioning toward high-margin specialized products like Steriport and ophthalmic solutions.
17:44 IST
NSE
Earnings Call
Amanta Healthcare Earnings Call: Key Takeaways
Amanta reported FY26 revenue of ₹288cr with 22% EBITDA margins. Strategy focuses on high-margin SteriPort capacity expansion and renewable energy cost savings.
15:27 IST
BSE
Earnings Call
Amanta Healthcare Earnings Call: Key Takeaways
Amanta Healthcare reported FY26 revenue of ₹288 Cr (+5% YoY) and PAT of ₹15 Cr (+42% YoY), driven by improved margins and reduced finance costs.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹185.80
- Market cap
- ₹721.5 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 39.4×Sector 41.3×
- Promoter holding
- 63.80%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.